Concord Drugs Ltd.
Snapshot View

View in App

Prices View details >>

26.92 +0.49 ▲1.9%

29 March 2023, 04:01:00 PM
Volume: 2,689

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.concorddrugs.in
Market Cap 24.31 Cr.
Enterprise Value(EV) 41.07 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 0.94 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 28.56 Trailing Twelve Months Ending 2022-12
Industry PE 32.00 Trailing Twelve Months Ending 2022-12
Book Value / Share 32.64 Trailing Twelve Months Ending 2022-12
Price to Book Value 0.82 Calculated using Price: 26.92
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.90 Cr. 9,029,610 Shares
FaceValue 10
Company Profile
Concord Drugs is engaged in developing new products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.85%
1 Week
-0.59%
1 Month
-5.54%
3 Month
-19.40%
6 Month
-19.40%
1 Year
-6.04%
2 Year
-10.27%
5 Year
+5.57%
10 Year

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 2.72 5.37 12.32 0.94 1.69 1.92 1.41 13.06 5.78
Return on Capital Employed (%) 7.15 11.33 15.90 8.84 7.49 6.17 6.06 15.69 9.30
Return on Assets (%) 0.79 1.41 3.28 0.30 0.40 0.43 0.47 6.08 3.00

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 15 13 15 19 19 23 23 27 28 29
Non Curr. Liab. 12 13 17 7 6 4 7 7 5 5
Curr. Liab. 18 28 21 29 81 56 27 16 23 20
Minority Int.
Equity & Liab. 45 54 52 56 106 83 58 50 56 54
Non Curr. Assets 21 19 16 25 14 13 12 14 15 14
Curr. Assets 23 36 37 30 92 70 46 36 42 40
Misc. Exp. not W/O
Total Assets 45 54 52 56 106 83 58 50 56 54

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 34 40 51 57 52 48 51 51 59 55
Other Income 0 0 0 0 0 0 0 0 0
Total Income 34 40 51 58 52 48 51 51 59 55
Total Expenditure -31 -33 -42 -52 -47 -44 -48 -48 -53 -51
PBIDT 3 7 8 6 5 4 3 3 6 4
Interest -2 -3 -3 -2 -2 -2 -2 -1 -2 -1
Depreciation -1 -4 -3 -3 -2 -2 -1 -1 -2 -2
Taxation 0 0 -1 0 0 0 0 -1 -1 0
Exceptional Items 4
PAT 0 1 2 0 0 0 0 3 2 1
Adjusted EPS 0 1 2 0 0 1 0 4 2 1

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 1 2 2 4 2 7 1 2 2 1
Cash Fr. Inv. -10 -2 -1 0 -1 -2 0 -1 -4 0
Cash Fr. Finan. 8 0 -1 -4 -4 -5 -1 -2 2 2
Net Change -1 0 0 0 -3 0 0 0 0 2
Cash & Cash Eqvt 0 0 0 0 -3 0 0 0 0 3

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 42.78 44.38 44.38 49.00 49.00 49.00 49.00 49.00 49.00
Public 57.22 55.62 55.62 51.00 51.00 51.00 51.00 51.00 51.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 28 Mar 2023
Closure of Trading Window
Closure of trading window under SEBI (Prohibition of Insider Trading) Regulations 2015.
Tue, 28 Mar 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On 28.03.2023.
Outcome of Board meeting held on 28.03.2023.
Mon, 27 Mar 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On 27.03.2023
Outcome of Board meeting held on 27.03.2023

Technical Scans View Details >>

Tue, 28 Mar 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 236,142.55 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. 75,408.82 4,564.50 +0.8%
Divi's Laboratories Ltd. 74,473.23 2,818.70 +0.5%
Cipla Ltd. 71,800.08 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. 62,246.53 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. 52,239.05 1,554.65 +0.7%
Zydus Lifesciences Ltd. 49,031.17 490.30 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.01 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.72 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 31.07 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 27.21 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 81.27 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.68 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.79 490.30 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.27 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.43 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 5.99 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 3.16 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.07 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.17 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.84 490.30 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 0.04 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 490.30 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 490.30 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 490.30 +1.2%

FAQ's On Concord Drugs Ltd.

What is Concord Drugs share price?
Can I buy Concord Drugs shares now?
What is the Market Cap of Concord Drugs?
What are the key metrics to analyse Concord Drugs?
What is the 52 Week High and Low of Concord Drugs?
What is the trend of Concord Drugs share price?